J&J names McCoy worldwide pharma head: Sheri McCoy is worldwide chairman of Johnson & Johnson's Pharmaceuticals Group, effective Jan. 1, 2009, filling the opening left by Christine Poon's retirement (1"The Tan Sheet" Sept. 15, 2008, p. 11). The New Brunswick, N.J.-based firm says Alex Gorsky will succeed McCoy as worldwide chairman of its Surgical Care Group, and also join the executive committee. Gorsky is currently the company group chairman and worldwide franchise chairman at J&J franchise Ethicon, Inc. "Sheri and Alex are proven leaders in driving high performance and developing talent across multiple business segments," says J&J CEO Bill Weldon
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
While the government announces eight to 15% cuts to the four products, industry groups urges for its operational improvement without expansion.
Returning FDA biologics center director Vinay Prasad used the Papzimeous approval announcement to reinforce his flexibility on rare disease therapies after several complete response letters and his brief departure from the agency.
Enhancing the consistency and clarity of information requests and discipline review letters, and improving assessment milestone communications are key areas targeted by generic drug makers for user fee program negotiations.
